Spots Global Cancer Trial Database for dendritic cells
Every month we try and update this database with for dendritic cells cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas | NCT02771301 | Glioma | dendritic cells | 18 Years - 70 Years | Hebei Yanda Hospital | |
| In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides | NCT02159937 | Metastatic Canc... | Blood sampling ... | 18 Years - | Recepta Biopharma | |
| Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma | NCT01944709 | Melanoma | Dendritic cell ... | 18 Years - | Cantonal Hospital of St. Gallen | |
| Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma | NCT03927222 | Glioblastoma | Human CMV pp65-... Temozolomide Tetanus-Diphthe... GM-CSF 111-Indium-labe... | 18 Years - | Duke University | |
| Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor | NCT01171469 | Brain Tumor Glioblastoma Medulloblastoma Ependymoma Anaplastic Astr... | Dendritic Cells Imiquimod | - | Masonic Cancer Center, University of Minnesota | |
| Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma | NCT03927222 | Glioblastoma | Human CMV pp65-... Temozolomide Tetanus-Diphthe... GM-CSF 111-Indium-labe... | 18 Years - | Duke University | |
| Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma | NCT04911621 | High Grade Glio... Diffuse Intrins... | Dendritic cell ... Dendritic cell ... | 12 Months - 17 Years | University Hospital, Antwerp | |
| Personalized Vaccine for Cancer Immunotherapy | NCT04879888 | Breast Cancer F... | Peptide pulsed ... | 18 Years - 65 Years | Universidad Nacional de Colombia | |
| Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer | NCT00311272 | Colorectal Neop... | MelCancerVac | 25 Years - 75 Years | University Hospital, Gentofte, Copenhagen | |
| A Vaccine Study for High Risk Cancers | NCT00944580 | Neuroblastoma Rhabdomyosarcom... Osteogenic Sarc... | MAGE-A1, MAGE-A... | 1 Year - 70 Years | Penn State University | |
| Intratumoral TriMix Injections in Early Breast Cancer Patients | NCT03788083 | Breast Cancer F... Early-stage Bre... | Trimix Placebo | 18 Years - 85 Years | Universitair Ziekenhuis Brussel | |
| PROvenge Treatment and Early Cancer Treatment | NCT00779402 | Prostate Cancer | Control Sipuleucel-T | 18 Years - 80 Years | Dendreon | |
| Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer | NCT02496273 | Gastric Cancer | CTL | 18 Years - 80 Years | The First People's Hospital of Changzhou | |
| Tumor RNA Transfected Dendritic Cell Vaccines | NCT00108264 | Prostate Cancer | Tumor RNA trans... | 10 Years - | VA Office of Research and Development | |
| Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 | NCT00197522 | Breast Neoplasm... | CD34+ derived D... | 16 Years - 80 Years | McMaster University | |
| Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response | NCT01128803 | Hepatocellular ... | injection of th... | 18 Years - 80 Years | Nantes University Hospital | |
| Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF | NCT00458536 | Renal Cancer | Dendritic Cell ... Granulocyte Mac... | 18 Years - | Beth Israel Deaconess Medical Center | |
| DC Vaccination for Postremission Therapy in AML | NCT01734304 | Acute Myeloid L... | DC vaccination ... | 18 Years - 75 Years | Ludwig-Maximilians - University of Munich | |
| DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma | NCT01353222 | Urothelial Carc... | DN24-02 Standard of Car... | 18 Years - | Dendreon | |
| DC Vaccination for Postremission Therapy in AML | NCT01734304 | Acute Myeloid L... | DC vaccination ... | 18 Years - 75 Years | Ludwig-Maximilians - University of Munich | |
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma | NCT04523688 | Glioblastoma Vaccination | Autologous Dend... Temozolomide | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients | NCT00243529 | Melanoma Stage ... | autologous dend... | 18 Years - 75 Years | Radboud University Medical Center | |
| Dendritic Cell Based Therapy of Metastatic Breast Cancer | NCT00197925 | Metastatic Brea... | Onco-peptide lo... | 18 Years - | Herlev Hospital | |
| Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) | NCT02772094 | Glioblastoma Mu... Glioblastoma | Single arm, ope... | 13 Years - 70 Years | China Medical University Hospital | |
| Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes | NCT00038870 | Acute Myelogeno... Chronic Myeloge... | Dendritic Cell ... | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma | NCT01875653 | Stage IV Melano... Stage III Melan... | Autologous Dend... Autologous PBMC... | 18 Years - | Lisata Therapeutics, Inc. | |
| DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab | NCT03688178 | Glioblastoma | Human CMV pp65-... Temozolomide Varlilumab Td Unpulsed DCs | 18 Years - | Duke University | |
| Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults | NCT02496520 | Sarcoma Central Nervous... | dendritic cells Surgery as need... Chemotherapy as... Radiation thera... | 3 Years - 40 Years | Clinica Universidad de Navarra, Universidad de Navarra | |
| Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF | NCT00458536 | Renal Cancer | Dendritic Cell ... Granulocyte Mac... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients | NCT02649582 | Glioblastoma Mu... | Dendritic cell ... | 18 Years - | University Hospital, Antwerp | |
| Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | NCT00795977 | Pancreatic Canc... | dendritic cells... | 20 Years - | Fukushima Medical University | |
| Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients | NCT02692976 | Prostatic Neopl... Immunotherapy Dendritic Cells Vaccines | mDC vaccination pDC vaccination mDC and pDC vac... | 18 Years - | Radboud University Medical Center | |
| Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes | NCT00048100 | Leukemia, Myelo... | Apheresis Stem Cell Trans... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) | NCT01347034 | Soft Tissue Sar... | External Beam R... Autologous Dend... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Probiotics In Colorectal Cancer Patients | NCT00936572 | Colorectal Canc... | Probiotics (La1... probiotics (La1... placebo | 18 Years - 80 Years | University of Milano Bicocca | |
| A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 | NCT00852007 | Prostate Cancer | DC-Tn-MUC1: aut... | 19 Years - | McMaster University | |
| DC1s-CTL Cellular Therapy for Renal Cell Carcinoma | NCT02787915 | Renal Cell Carc... | DC1-CTL | 18 Years - 80 Years | Xuzhou Medical University | |
| Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | NCT00228189 | Colorectal Canc... Liver Metastase... | CEA-loaded dend... | 18 Years - 75 Years | Radboud University Medical Center | |
| Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC | NCT03226236 | Carcinoma, Rena... Vaccination Secondary | boost radiother... Autologous DC v... High-Dose IL-2 | 19 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients | NCT00847106 | Melanoma | Daclizumab Dendritic cells | 18 Years - 75 Years | Radboud University Medical Center | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation | NCT00363467 | Acute Myeloid L... | G-CSF Leukapheresis Busulfan Stem cell reinf... | 56 Years - 74 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma | NCT01241682 | Malignant (Pleu... | DC + CTX | - | Erasmus Medical Center | |
| Probiotics In Colorectal Cancer Patients | NCT00936572 | Colorectal Canc... | Probiotics (La1... probiotics (La1... placebo | 18 Years - 80 Years | University of Milano Bicocca | |
| Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients | NCT00847106 | Melanoma | Daclizumab Dendritic cells | 18 Years - 75 Years | Radboud University Medical Center | |
| Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor | NCT01171469 | Brain Tumor Glioblastoma Medulloblastoma Ependymoma Anaplastic Astr... | Dendritic Cells Imiquimod | - | Masonic Cancer Center, University of Minnesota | |
| Intratumoral TriMix Injections in Early Breast Cancer Patients | NCT03788083 | Breast Cancer F... Early-stage Bre... | Trimix Placebo | 18 Years - 85 Years | Universitair Ziekenhuis Brussel | |
| Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer | NCT03638765 | Brain Metastase... Lung Cancer Met... Breast Cancer M... | DCVax-Direct | 18 Years - 75 Years | Northwest Biotherapeutics | |
| MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer | NCT00374049 | Prostate Cancer | MUC_1 | 18 Years - | University of Pittsburgh | |
| Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients | NCT01690377 | Melanoma | PDC or myDC | 18 Years - 75 Years | Radboud University Medical Center | |
| Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer | NCT00045968 | Glioblastoma Mu... Glioblastoma GBM Grade IV Astroc... Glioma Brain Cancer Brain Tumor | Dendritic cell ... | 18 Years - 70 Years | Northwest Biotherapeutics | |
| Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 | NCT00197522 | Breast Neoplasm... | CD34+ derived D... | 16 Years - 80 Years | McMaster University | |
| Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | NCT00228189 | Colorectal Canc... Liver Metastase... | CEA-loaded dend... | 18 Years - 75 Years | Radboud University Medical Center | |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer | NCT01431391 | Prostatic Neopl... Prostate Cancer Prostatic Adeno... | sipuleucel-T leuprolide acet... | 18 Years - | Dendreon | |
| Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response | NCT01128803 | Hepatocellular ... | injection of th... | 18 Years - 80 Years | Nantes University Hospital | |
| Immunogenicity and Safety of DCs in Breast Cancer | NCT03450044 | Breast Cancer F... | Dendritic cells | 30 Years - 65 Years | Fundación Salud de los Andes | |
| Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes | NCT00038870 | Acute Myelogeno... Chronic Myeloge... | Dendritic Cell ... | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Probiotics In Colorectal Cancer Patients | NCT00936572 | Colorectal Canc... | Probiotics (La1... probiotics (La1... placebo | 18 Years - 80 Years | University of Milano Bicocca | |
| A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma | NCT01677962 | Pancreatic Aden... | Poly-ICLC dendritic cell | 18 Years - | Medical University of South Carolina | |
| DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma | NCT01353222 | Urothelial Carc... | DN24-02 Standard of Car... | 18 Years - | Dendreon | |
| Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38 | NCT00912574 | Melanoma | GM-CSF-in-adjuv... Montanide ISA-5... GM-CSF and Mont... Saline | 18 Years - 85 Years | University of Virginia | |
| Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients | NCT02285413 | Melanoma | DC vaccination DC vaccination ... | 18 Years - 70 Years | Radboud University Medical Center | |
| Immunogenicity and Safety of DCs in Breast Cancer | NCT03450044 | Breast Cancer F... | Dendritic cells | 30 Years - 65 Years | Fundación Salud de los Andes | |
| Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | NCT00065442 | Prostate Cancer | Sipuleucel-T APC-Placebo | 18 Years - | Dendreon | |
| To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen | NCT00715078 | Prostate Cancer | sipuleucel-T | 18 Years - | Dendreon | |
| Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection | NCT00243594 | Melanoma Stage ... | Peptide-pulsed ... | 18 Years - 75 Years | Radboud University Medical Center | |
| Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients | NCT00243529 | Melanoma Stage ... | autologous dend... | 18 Years - 75 Years | Radboud University Medical Center | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer | NCT00311272 | Colorectal Neop... | MelCancerVac | 25 Years - 75 Years | University Hospital, Gentofte, Copenhagen | |
| A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma | NCT01677962 | Pancreatic Aden... | Poly-ICLC dendritic cell | 18 Years - | Medical University of South Carolina | |
| Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma | NCT04911621 | High Grade Glio... Diffuse Intrins... | Dendritic cell ... Dendritic cell ... | 12 Months - 17 Years | University Hospital, Antwerp | |
| Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells | NCT04105582 | Breast Cancer Triple Negative... | Neo-antigen pul... | 18 Years - 75 Years | Universidad Nacional de Colombia | |
| A Vaccine Study for High Risk Cancers | NCT00944580 | Neuroblastoma Rhabdomyosarcom... Osteogenic Sarc... | MAGE-A1, MAGE-A... | 1 Year - 70 Years | Penn State University | |
| Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer | NCT04789252 | Non-small Cell ... | Bioinformatics ... | 18 Years - | University of Milano Bicocca | |
| Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma | NCT00338377 | Melanoma | Dendritic Cell ... Cyclophosphamid... Fludarabine T-Cells Interleukin-2 Mesna Intrathecal T-C... Intrathecal Int... | 12 Years - | M.D. Anderson Cancer Center | |
| Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer | NCT00901342 | Prostate Cancer | sipuleucel-T | 18 Years - | Dendreon | |
| MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer | NCT00374049 | Prostate Cancer | MUC_1 | 18 Years - | University of Pittsburgh | |
| Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma | NCT01348256 | Colorectal Carc... Hepatic Metasta... | Dendritic cells... | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients | NCT00243529 | Melanoma Stage ... | autologous dend... | 18 Years - 75 Years | Radboud University Medical Center | |
| Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer | NCT01897207 | Cancer of the P... | Dendritic cell ... | 18 Years - | Cantonal Hospital of St. Gallen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
